Donate to Illuminate Contact TSF
Visit us on Facebook Visit us on Twitter Visit us on YouTube Visit us on Instagram Visit us on Linkedin Visit us on Tiktok
Loading Events

« All Events

  • This event has passed.

Approved NMOSD Therapies

June 21 @ 12:00 pm - 1:00 pm EDT

In 2014, there were 0 FDA-approved therapies for patients living with neuromyelitis optica spectrum disorder (NMOSD). In 2024, there are 4 efficacious, FDA-approved therapies available for patients living with NMOSD.

You’re invited to “Approved NMOSD Therapies” a live webinar during which Dr. Sean Pittock* of the Mayo Clinic will provide overviews (pharmacology, drug delivery method, dosing, frequency, side effects, reduction in relapse rates, antibody criteria, etc.) of each approved therapy.

We invite patients, caregivers, clinicians, researchers, advocates, industry professionals or anyone interested in NMOSD to join this educational program. Live attendees will have the opportunity to ask Dr. Pittock questions in real time.

This webinar will be recorded and made available for replay on TSF’s YouTube channel and global website.

*Sean J. Pittock, M.D.
Consultant, Department of Neurology
Professor of Neurology
Marilyn A Park and Moon S. Park, M.D. Director of the Mayo Clinic’s Center for Multiple Sclerosis and Autoimmune Neurology,
Applebaum Family Professor of Neurosciences

Details

Date:
June 21
Time:
12:00 pm - 1:00 pm EDT
Event Category:
Website:
Register »

Venue

Virtual: Global

Industry Partners

Community Partners

WARNING: Internet Explorer does not support modern web standards. This site may not function correctly on this browser and is best viewed on Chrome, Firefox or Edge browsers. Learn More.